Quarterly report pursuant to Section 13 or 15(d)

Stock Options

v3.21.1
Stock Options
6 Months Ended
Feb. 28, 2021
Share-based Payment Arrangement [Abstract]  
Stock Options

13.

Stock Options

 

 

 

The Company has established the 2014 Stock Option Plan whereby the board of directors may, from time to time, grant up to 62,917 stock options to directors, officers, employees, and consultants; and the 2019 Equity Incentive Plan whereby the board of directors may, from time to time, grant up to 261,290 stock options to directors, officers, employees, and consultants. Stock options granted must be exercised no later than five years from the date of grant or such lesser period as determined by the Company's board of directors. The exercise price of an option is equal to or greater than the closing market price of the Company's common shares on the day preceding the date of grant. The vesting terms of each grant are set by the board of directors.

 

 

 

The Company granted the following options during the quarter ended February 28, 2021:

 

Quantity

 

 

Exercise Price $

 

 

Life (Years)

 

 

3,400

 

 

 

4.80

 

 

5

 

 

 

A continuity schedule for stock options is presented below:

 

 

Options

 

 

Weighted Average Exercise Price $

 

 

Weighted Average Remaining Contractual Term (Years)

 

 

Aggregate Intrinsic Value $

 

Balance August 31, 2019

 

 

166,767

 

 

 

21.30

 

 

 

 

 

 

 

Cancelled/expired

 

 

(149,437 )

 

 

29.51

 

 

 

 

 

 

 

Exercised

 

 

(7,333 )

 

 

4.09

 

 

 

 

 

 

 

Granted

 

 

161,600

 

 

 

11.66

 

 

 

 

 

 

 

Balance August 31, 2020

 

 

171,604

 

 

 

11.17

 

 

 

 

 

 

 

Cancelled

 

 

(2,000 )

 

 

12.90

 

 

 

 

 

 

 

Granted

 

 

3,400

 

 

 

4.80

 

 

 

 

 

 

 

Balance February 28, 2021 (Outstanding)

 

 

173,004

 

 

 

11.03

 

 

 

3.82

 

 

 

30,812

 

Balance February 28, 2021 (Exercisable)

 

 

164,970

 

 

 

10.30

 

 

 

3.86

 

 

 

41,550

 

 

The fair value of share purchase options granted were estimated as of the date of the grant by using the Black-Scholes option pricing model with the following assumptions:

 

 

 

February 28

2021

 

Expected volatility

 

 

134 %

Risk-free interest rate

 

 

0.42 %

Expected life

 

5 years

 

Dividend yield

 

 

0 %

Estimated fair value per option

 

$ 4.00